Calls
1
u/MannerProfessional24
Reddit r/stocks
Win Rate
0.0%
return
-27.4%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Feb 12
$6.90
-27.4%
The author identifies Vanda Pharma as his single stock pick among biotechs with potential milestone events this month, citing its growing commercial base with Fanapt and the recent Nereus trapitant approval for motion sickness. The key catalyst is the February 21 FDA decision date for Bysanti, a new antipsychotic for bipolar I disorder and schizophrenia, which would expand VNDA's commercial portfolio into a larger psychiatric market. He notes the company is well funded with $263.8 million, reducing near-term dilution risk, and sees multiple catalysts in 2026.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/MannerProfessional24 has 1 trade ideas tracked on Buzzberg across 1 tickers since February 2026. Most covered: VNDA.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
